Clinicaltrials.gov 中文
WebApr 12, 2024 · ClinicalTrials.gov: If an award provides for one or more clinical trials. By law (Title VIII, Section 801 of Public Law 110-85), the "responsible party" must register and submit results information for certain “applicable clinical trials” on the ClinicalTrials.gov Protocol Registration and Results System Information Website ... WebFill in any or all of the fields below. Click on the label to the left of each search field for more information or read the Help. Condition or disease: Other terms: Study type: Study Results: Status: Recruitment: Not yet recruiting.
Clinicaltrials.gov 中文
Did you know?
WebMay 14, 2024 · ClinicalTrials.gov Identifier: NCT04886596 Other Study ID Numbers: 212494 2024-000753-28 ( EudraCT Number ) First Posted: May 14, 2024 Key Record Dates: Last Update Posted: June 30, 2024 Last Verified: June 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Yes: Plan Description: ... WebAug 18, 2024 · ClinicalTrials.gov Identifier: NCT05011513 Other Study ID Numbers: C4671002 2024-002857-28 ( EudraCT Number ) EPIC-SR ( Other Identifier: Alias Study Number ) First Posted: August 18, 2024 Key Record Dates: Last Update Posted: December 12, 2024 Last Verified: December 2024
WebApr 12, 2024 · The National Cancer Institute, part of the National Institutes of Health (NIH), has helped launch a phase 3 randomized clinical trial (NCT05633602) of a two-drug combination to treat patients with advanced non-small cell lung cancer (NSCLC).Called the Pragmatica-Lung Study (or S2302), this is one of the first NCI-supported clinical trials … WebAug 13, 2024 · ClinicalTrials.gov Identifier: NCT04512235 Other Study ID Numbers: CAEL101-302 : First Posted: August 13, 2024 Key Record Dates: Last Update Posted: March 1, 2024 Last Verified: February 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Yes: Plan Description: ...
WebNov 6, 2024 · ClinicalTrials.gov Identifier: NCT04153149 Other Study ID Numbers: ALN-TTRSC02-003 2024-003153-28 ( EudraCT Number ) First Posted: November 6, 2024 Key Record Dates: Last Update Posted: March 21, 2024 Last Verified: March 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No WebTo use the Advanced Search form, enter search terms in one or more fields and then click on Search. A list of search results will be displayed. The total number of studies found is shown below the search box, along with your search terms. The first column of the search results list, Row, indicates the order in which the studies are listed.
ClinicalTrials.gov is a registry of clinical trials. It is run by the United States National Library of Medicine (NLM) at the National Institutes of Health, and holds registrations from over 444,000 trials from 221 countries.
WebApr 13, 2024 · ClinicalTrials.gov Identifier: NCT05811247 Other Study ID Numbers: APC-APN-304 : First Posted: April 13, 2024 Key Record Dates: Last Update Posted: April 13, 2024 Last Verified: March 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ... mchenry housing authority.orgWebApr 17, 2024 · Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Perez-Garcia J, Soberino J, Racca F, Gion M, Stradella A, Cortes J. Atezolizumab in the treatment of metastatic triple-negative breast cancer. Expert Opin Biol Ther. 2024 Sep;20(9):981-989. doi: 10.1080/14712598.2024.1769063. mchenry high school illinoisWebApr 12, 2024 · Inclusion Criteria: Patients must meet all of the following criteria to be eligible for inclusion: Age between 18 and 80 years (inclusive); Imaging findings consistent with unresectable local advanced, recurrent or metastatic duodenal adenocarcinoma; Histologically confirmed unresectable local advanced, recurrent or metastatic duodenal … liberty st milford ctWebApr 13, 2024 · ClinicalTrials.gov Identifier: NCT05811481 Other Study ID Numbers: [2024]662 : First Posted: April 13, 2024 Key Record Dates: Last Update Posted: April 13, 2024 Last Verified: April 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No: Plan Description: ... mchenry howeWebApr 5, 2024 · This study is a Phase 1, multicenter, open-label study designed to evaluate the safety and efficacy of MT-601 in patients with relapsed or refractory Non-Hodgkin lymphoma (NHL) who either received CD19+ chimeric antigen receptor (CAR) T cell therapy or are ineligible for CD19+ CAR T cell therapy. liberty st louisWebApr 7, 2024 · ClinicalTrials.gov Identifier: NCT04336982 Other Study ID Numbers: CC-90009-AML-002 U1111-1247-5619 ( Other Identifier: WHO ) 2024-001681-15 ( EudraCT Number ) First Posted: April 7, 2024 Key Record Dates: Last Update Posted: March 10, 2024 Last Verified: March 2024 ... liberty st morris ilWebJun 15, 2024 · ClinicalTrials.gov Identifier: NCT04927065 Other Study ID Numbers: mRNA-1273-P205 : First Posted: June 15, 2024 Key Record Dates: Last Update Posted: November 18, 2024 Last Verified: November 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ... mchenry high school warriors